• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of jexpmedHomeThe Rockefeller University PressEditorsContactInstructions for AuthorsThis issue
J Exp Med. Feb 1, 1989; 169(2): 431–445.
PMCID: PMC2189214

Spontaneous recovery of rats from experimental allergic encephalomyelitis is dependent on regulation of the immune system by endogenous adrenal corticosteroids

Abstract

Lewis rats with experimental allergic encephalomyelitis (EAE), induced either by the subcutaneous injection of guinea pig myelin basic protein (MBP) or by the adoptive transfer of MBP-primed spleen cells, suffer from a single episode of paralysis from which they recover spontaneously. Animals developing EAE were found to have greatly elevated levels of corticosterone in the blood. This endogenous increase in steroid production was accompanied by lymphopenia and depressed delayed-type hypersensitivity responses to OVA, indicating that rats with EAE are immunosuppressed in an antigen-nonspecific fashion. Adrenalectomized rats given subcutaneous implants of corticosterone to maintain basal steroid levels invariably died when EAE was induced. However, if the steroid replacement therapy was adjusted to mimic the hormone levels that were observed in intact rats developing EAE, then the disease followed a nonfatal course closely resembling that seen in the nonadrenalectomized controls. Replacement therapy that achieved serum corticosterone levels slightly higher than those found in intact rats with EAE virtually suppressed the disease completely. It is concluded that endogenous corticosterone release in rats with EAE plays an essential role in the spontaneous recovery that is observed in this condition. However, the subsequent refractory phase that is characteristic of rats that have recovered from EAE induced by active immunization with MBP is not associated with chronically elevated corticosterone levels. This finding is discussed in the light of other data that suggest that unlike the spontaneous recovery, the refractory state has an immunological basis rather than an endocrinological basis.

Full Text

The Full Text of this article is available as a PDF (847K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Raine CS. Biology of disease. Analysis of autoimmune demyelination: its impact upon multiple sclerosis. Lab Invest. 1984 Jun;50(6):608–635. [PubMed]
  • Sedgwick J, Brostoff S, Mason D. Experimental allergic encephalomyelitis in the absence of a classical delayed-type hypersensitivity reaction. Severe paralytic disease correlates with the presence of interleukin 2 receptor-positive cells infiltrating the central nervous system. J Exp Med. 1987 Apr 1;165(4):1058–1075. [PMC free article] [PubMed]
  • Goldmuntz EA, Brosnan CF, Norton WT. Prazosin treatment suppresses increased vascular permeability in both acute and passively transferred experimental autoimmune encephalomyelitis in the Lewis rat. J Immunol. 1986 Dec 1;137(11):3444–3450. [PubMed]
  • Hinrichs DJ, Roberts CM, Waxman FJ. Regulation of paralytic experimental allergic encephalomyelitis in rats: susceptibility to active and passive disease reinduction. J Immunol. 1981 May;126(5):1857–1862. [PubMed]
  • Adda DH, Beraud E, Depieds R. Evidence for suppressor cells in Lewis rats' experimental allergic encephalomyelitis. Eur J Immunol. 1977 Sep;7(9):620–623. [PubMed]
  • Ellerman KE, Powers JM, Brostoff SW. A suppressor T-lymphocyte cell line for autoimmune encephalomyelitis. Nature. 1988 Jan 21;331(6153):265–267. [PubMed]
  • Bernard CC. Suppressor T cells prevent experimental autoimmune encephalomyelitis in mice. Clin Exp Immunol. 1977 Jul;29(1):100–109. [PMC free article] [PubMed]
  • Welch AM, Holda JH, Swanborg RH. Regulation of experimental allergic encephalomyelitis. II. Appearance of suppressor cells during the remission phase of the disease. J Immunol. 1980 Jul;125(1):186–189. [PubMed]
  • Welch AM, Swierkosz JE, Swanborg RH. Regulation of self tolerance in experimental allergic encephalomyelitis. I. Differences between lymph node and spleen suppressor cells. J Immunol. 1978 Nov;121(5):1701–1705. [PubMed]
  • Lider O, Reshef T, Beraud E, Ben-Nun A, Cohen IR. Anti-idiotypic network induced by T cell vaccination against experimental autoimmune encephalomyelitis. Science. 1988 Jan 8;239(4836):181–183. [PubMed]
  • PATERSON PY, HARWIN SM. Suppression of allergic encephalomyelitis in rats by means of antibrain serum. J Exp Med. 1963 May 1;117:755–774. [PMC free article] [PubMed]
  • Hughes RA. Protection of rats from experimental allergic encephalomyelitis with antiserum to guinea-pig spinal cord. Immunology. 1974 Apr;26(4):703–711. [PMC free article] [PubMed]
  • NAKAO A, ROBOZ-EINSTEIN E. CHEMICAL AND IMMUNOCHEMICAL STUDIES WITH A DIALYZABLE ENCEPHALITOGENIC COMPOUND FROM BOVINE SPINAL CORD. Ann N Y Acad Sci. 1965 Mar 31;122:171–181. [PubMed]
  • Fontana A, Kristensen F, Dubs R, Gemsa D, Weber E. Production of prostaglandin E and an interleukin-1 like factor by cultured astrocytes and C6 glioma cells. J Immunol. 1982 Dec;129(6):2413–2419. [PubMed]
  • de Martin R, Haendler B, Hofer-Warbinek R, Gaugitsch H, Wrann M, Schlüsener H, Seifert JM, Bodmer S, Fontana A, Hofer E. Complementary DNA for human glioblastoma-derived T cell suppressor factor, a novel member of the transforming growth factor-beta gene family. EMBO J. 1987 Dec 1;6(12):3673–3677. [PMC free article] [PubMed]
  • Oropeza RL, Wekerle H, Werb Z. Expression of apolipoprotein E by mouse brain astrocytes and its modulation by interferon-gamma. Brain Res. 1987 Apr 28;410(1):45–51. [PubMed]
  • Billiau A, Heremans H, Vandekerckhove F, Dijkmans R, Sobis H, Meulepas E, Carton H. Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFN-gamma. J Immunol. 1988 Mar 1;140(5):1506–1510. [PubMed]
  • Levine S, Sowinski R, Steinetz B. Effects of experimental allergic encephalomyelitis on thymus and adrenal: relation to remission and relapse. Proc Soc Exp Biol Med. 1980 Nov;165(2):218–224. [PubMed]
  • Chelmicka-Schorr E, Checinski M, Arnason BG. Chemical sympathectomy augments the severity of experimental allergic encephalomyelitis. J Neuroimmunol. 1988 Mar;17(4):347–350. [PubMed]
  • Sedgwick JD. Long-term depletion of CD8+ T cells in vivo in the rat: no observed role for CD8+ (cytotoxic/suppressor) cells in the immunoregulation of experimental allergic encephalomyelitis. Eur J Immunol. 1988 Apr;18(4):495–502. [PubMed]
  • Sriram S, Carroll L. In vivo depletion of Lyt-2 cells fails to alter acute and relapsing EAE. J Neuroimmunol. 1988 Jan;17(2):147–157. [PubMed]
  • Willenborg DO, Sjollema P, Danta G. Immunoregulation of passively induced allergic encephalomyelitis. J Immunol. 1986 Mar 1;136(5):1676–1679. [PubMed]
  • Brostoff SW, Mason DW. Experimental allergic encephalomyelitis: successful treatment in vivo with a monoclonal antibody that recognizes T helper cells. J Immunol. 1984 Oct;133(4):1938–1942. [PubMed]
  • Richert JR, Driscoll BF, Kies MW, Alvord EC., Jr Adoptive transfer of experimental allergic encephalomyelitis: incubation of rat spleen cells with specific antigen. J Immunol. 1979 Feb;122(2):494–496. [PubMed]
  • Sedgwick JD, Mason DW. The mechanism of inhibition of experimental allergic encephalomyelitis in the rat by monoclonal antibody against CD4. J Neuroimmunol. 1986 Dec;13(2):217–232. [PubMed]
  • Cook DM, Kendall JW, Greer MA, Kramer RM. The effect of acute or chronic ether stress on plasma ACTH concentration in the rat. Endocrinology. 1973 Nov;93(5):1019–1024. [PubMed]
  • Krey LC, Lu KH, Bulter WR, Hotchkiss J, Piva F, Knobil E. Surgical disconnection of the medial basal hypothalamus and pituitary function in the rhesus monkey. II. GH and cortisol secretion. Endocrinology. 1975 May;96(5):1088–1093. [PubMed]
  • Meyer JS, Micco DJ, Stephenson BS, Krey LC, McEwen BS. Subcutaneous implantation method for chronic glucocorticoid replacement therapy. Physiol Behav. 1979 May;22(5):867–870. [PubMed]
  • GOWANS JL. The recirculation of lymphocytes from blood to lymph in the rat. J Physiol. 1959 Apr 23;146(1):54–69. [PMC free article] [PubMed]
  • Rosenthale ME, Datko LJ, Kassarich J, Schneider F. Chemotherapy of experimental allergic encephalomyelitis (EAE). Arch Int Pharmacodyn Ther. 1969 Jun;179(2):251–275. [PubMed]
  • Craddock CG. Corticosteroid-induced lymphopenia, immunosuppression, and body defense. Ann Intern Med. 1978 Apr;88(4):564–566. [PubMed]
  • Reinhardt WO, Li CH. DEPRESSION OF LYMPHOCYTE CONTENT OF THORACIC DUCT LYMPH BY ADRENOCORTICOTROPHIC HORMONE. Science. 1945 Apr 6;101(2623):360–361. [PubMed]
  • McFarlin DE, Blank SE, Kibler RF. Recurrent experimental allergic encephalomyelitis in the Lewis rat. J Immunol. 1974 Aug;113(2):712–715. [PubMed]
  • Keith AB. Sex difference in Lewis rats in the incidence of recurrent experimental allergic encephalomyelitis. Nature. 1978 Apr 27;272(5656):824–825. [PubMed]
  • Bertini R, Bianchi M, Ghezzi P. Adrenalectomy sensitizes mice to the lethal effects of interleukin 1 and tumor necrosis factor. J Exp Med. 1988 May 1;167(5):1708–1712. [PMC free article] [PubMed]
  • Cupps TR, Fauci AS. Corticosteroid-mediated immunoregulation in man. Immunol Rev. 1982;65:133–155. [PubMed]
  • LEVINE S, STREBEL R, WENK EJ, HARMAN PJ. Suppression of experimental allergic encephalomyelitis by stress. Proc Soc Exp Biol Med. 1962 Feb;109:294–298. [PubMed]
  • Komarek A, Dietrich FM. Chemical prevention of experimental allergic encephalomyelitis in rats: a quantitative evaluation of steroids and various non-steroid drugs. Arch Int Pharmacodyn Ther. 1971 Oct;193(2):249–257. [PubMed]
  • Ellison GW, Myers LW. A review of systemic nonspecific immunosuppressive treatment of multiple sclerosis. Neurology. 1978 Sep;28(9 Pt 2):132–139. [PubMed]
  • MOYER AW, JERVIS GA, BLACK J, KOPROWSKI H, COX HR. Action of adrenocorticotropic hormone (ACTH) in experimental allergic encephalomyelitis of the guinea pig. Proc Soc Exp Biol Med. 1950 Nov;75(2):387–390. [PubMed]
  • Snyder DS, Unanue ER. Corticosteroids inhibit murine macrophage Ia expression and interleukin 1 production. J Immunol. 1982 Nov;129(5):1803–1805. [PubMed]
  • Gillis S, Crabtree GR, Smith KA. Glucocorticoid-induced inhibition of T cell growth factor production. I. The effect on mitogen-induced lymphocyte proliferation. J Immunol. 1979 Oct;123(4):1624–1631. [PubMed]
  • SHAW CM, ALVORD EC, Jr, KAKU J, KIES MW. CORRELATION OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS WITH DELAYED-TYPE SKIN SENSITIVITY TO SPECIFIC HOMOLOGOUS ENCEPHALITOGEN. Ann N Y Acad Sci. 1965 Mar 31;122:318–331. [PubMed]
  • McGraw TP, Swanborg RH. Cell-mediated immunity to myelin basic protein in Lewis rats made unresponsive to experimental allergic encephalomyelitis. Eur J Immunol. 1978 Dec;8(12):905–909. [PubMed]
  • Long JB, Holaday JW. Blood-brain barrier: endogenous modulation by adrenal-cortical function. Science. 1985 Mar 29;227(4694):1580–1583. [PubMed]
  • Bernton EW, Beach JE, Holaday JW, Smallridge RC, Fein HG. Release of multiple hormones by a direct action of interleukin-1 on pituitary cells. Science. 1987 Oct 23;238(4826):519–521. [PubMed]
  • Sapolsky R, Rivier C, Yamamoto G, Plotsky P, Vale W. Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor. Science. 1987 Oct 23;238(4826):522–524. [PubMed]
  • Weigent DA, Blalock JE. Interactions between the neuroendocrine and immune systems: common hormones and receptors. Immunol Rev. 1987 Dec;100:79–108. [PubMed]
  • Besedovsky H, del Rey A, Sorkin E, Dinarello CA. Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science. 1986 Aug 8;233(4764):652–654. [PubMed]
  • Munck A, Guyre PM, Holbrook NJ. Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocr Rev. 1984 Winter;5(1):25–44. [PubMed]
  • Kroemer G, Brezinschek HP, Faessler R, Schauenstein K, Wick G. Physiology and pathology of an immunoendocrine feedback loop. Immunol Today. 1988 Jun;9(6):163–165. [PubMed]
  • Willenborg DO. Experimental allergic encephalomyelitis in the Lewis rat: studies on the mechanism of recovery from disease and acquired resistance to reinduction. J Immunol. 1979 Sep;123(3):1145–1150. [PubMed]
  • Polman CH, Matthaei I, de Groot CJ, Koetsier JC, Sminia T, Dijkstra CD. Low-dose cyclosporin A induces relapsing remitting experimental allergic encephalomyelitis in the Lewis rat. J Neuroimmunol. 1988 Feb;17(3):209–216. [PubMed]
  • Minagawa H, Takenaka A, Itoyama Y, Mori R. Experimental allergic encephalomyelitis in the Lewis rat. A model of predictable relapse by cyclophosphamide. J Neurol Sci. 1987 Apr;78(2):225–235. [PubMed]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

  • Compound
    Compound
    PubChem Compound links
  • MedGen
    MedGen
    Related information in MedGen
  • PubMed
    PubMed
    PubMed citations for these articles
  • Substance
    Substance
    PubChem Substance links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...